10/20/2026
The first question most patients ask after starting a GLP-1 is "how much weight have I lost?" And when the number on the scale doesn't match expectations, the assumption is that the medication isn't doing its job.
But weight loss is only one outcome of GLP-1 therapy. And it's rarely the first one.
At lower doses, before appetite suppression fully takes effect, these medications are already working on your metabolic infrastructure. Insulin sensitivity improves. Inflammatory markers in the liver begin to decrease. Fasting glucose stabilizes. Cardiovascular risk markers trend downward.
These are measurable, meaningful changes. They just don't show up on a bathroom scale.
This is especially important during the early titration phase, when doses are intentionally kept low and increased gradually. Patients often feel like nothing is happening. But metabolically, a lot is.
The risk of judging a GLP-1 only by the scale is that patients discontinue too early, before the medication reaches its full therapeutic window. Or they push for faster dose increases when the current dose is already producing internal benefits worth protecting.
Weight will follow. But the metabolic foundation is being built right now.
✅ Book your Metabolic Health Evaluation and get a full picture of how your GLP-1 is performing beyond the scale.
📲 Share this with someone who's frustrated their GLP-1 "isn't working."
💻 Office Hours: Monday-Thursday | 5pm - 8pm
www.priorityhealth.biz
608-359-9541
[email protected]